Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Effect of EGFR over-expression in radiotherapy for HPV-positive HNSCC.

COVID-19 Research Scientist Jobs With Rs. 48,000 pm Pay For Life Sciences at PGIMER

Govt RGCB Molecular Biology Project Assistant Recruitment

Effect of EGFR over-expression in radiotherapy for HPV-positive HNSCC.
  • BiotechToday
  • World

Effect of EGFR over-expression in radiotherapy for HPV-positive HNSCC.

bioxone November 3, 2020November 3, 2020

Richismita Hazra, Amity University Kolkata

Human Papillomavirus (HPV) related head and neck cancer is identified as a distinct tumor entity with an elevated incidence reported for several countries. These tumors arise from squamous cells, ordinarily in the oropharynx. In contrast to other risk factors that are associated with cancer, HPV related cancer is driven by viral oncoprotein activity and has individual profiles regarding protein expression, genetic and epigenetic alterations. The treatment modality for commending prophesy of HPV related head and neck squamous cell carcinoma (HNSCC) consists of high dose radiotherapy in combination with chemotherapy. The treatment techniques however show similarity with HPV-negative tumors and are associated with toxic side effects. 

Epidermal growth factor receptor (EGFR) is a transmembrane receptor protein involved in cell signaling pathways that control cell division and survival. EGFR is overexpressed in more than 80% of HNSCC and it corresponds to resistance towards radiotherapy. Cetuximab, EGFR inhibiting monoclonal antibody is the only FDA accepted targeted therapy for both HNSCC subtypes but the responses differ between the subtypes. 

The role of EGFR in HPV-positive HNSCC response to radiotherapy has been reported in this investigation. In HPV-positive HNSCC cell lines, EFGR activation firmly showed an increased radiotherapy response in vitro and in vivo. EGFR was observed to be involved in the downregulation of HPV E6 expression and induction of P53 activity in response to radiotherapy. This report provides insights into the use of EGFR targeted therapies in the context of the genetic makeup of cancer.  

Also read: Regulatory expression of Co-inhibitory receptors by Type 1 Interferon transcriptional network in human T cells

Source:  EGFR overexpression increases radiotherapy response in HPV-Positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation. https://doi.org/10.1016/j.canlet.2020.10.035

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged cancer Cancer cell lines Cancer genetics Cancer Therapy cancer treatment Carcinoma chemotherapy EGFR EGFR signaling Genetic makeup Head Head and neck cancer HPV E6 Neck Oropharyngeal squamous cell carcinoma (OPSCC) Overexpression P53 radiation Radiotherapy tumours

One thought on “Effect of EGFR over-expression in radiotherapy for HPV-positive HNSCC.”

  1. Pingback: ConCysFind – Easing the identification of preserved AA based on phylogenetic occurrence - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Govt RGCB Molecular Biology Project Assistant Recruitment

bioxone November 3, 2020

-Shristi Sharma, Team bioXone Govt Mol Biology Jobs – Project Assistant Vacancy. RGCB, Thiruvananthapuram is hiring MSc Life/Biological Science & Molecular Biology candidates. Life Science Job Opening. Interested and eligible candidates can check out all of the details below: Adv. # 15/2020 NAME OF THE POST: Project Assistant NAME OF THE PROJECT: “Intracellular trafficking and […]

Related Post

  • BiotechToday
  • World

Dangerous Eye abnormalities linked to COVID-19, Revealed by MRI scans?

bioxone February 27, 2021February 27, 2021

Anannya Roy, Amity University Kolkata The world has suffered from the impact of the COVID-19 pandemic since the beginning of 2020. Though scientists are working hard day and night to tackle the situation, it always seems like the virus has the upper hand. Recently, a shocking discovery was made that puzzled Researchers and Doctors from […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Splicing factor SF3B1 promotes endometrial carcinoma progression?

bioxone October 12, 2020October 11, 2020

Arjama Roy, Amity University Kolkata Endometrial cancer is the foremost common type of cancer that affects the feminine reproductive tract. It grows rapidly and tends to spread to other parts of the body. Earlier, the causative agent of endometrial carcinoma wasn’t known aside from the transcriptional effects of steroid hormones. As a result of which limited therapeutic options were provided to the diagnosed women. Recent work […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

A potential Covid vaccine for Multiple Myeloma Patients

BioTech Today July 4, 2021July 4, 2021

Saptaparna Dasgupta, Bennett University The risk of COVID19 infection is exceeded in multiple myeloma patients. Vaccine for the general population with BNT162b2 mRNA COVID19 (BNT162b2) provides effective protection against COVID19. However, their efficacy on patients with multiple myeloma may be adversely affected by and not yet assessed due to factors related to disease and therapy. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy